These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15687414

  • 1. Pathophysiology and long-term management of the metabolic syndrome.
    Pi-Sunyer FX.
    Obes Res; 2004 Dec; 12 Suppl():174S-80S. PubMed ID: 15687414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC, Tong PC, Critchley JA.
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S, Nakamura K, Takeuchi M.
    Med Hypotheses; 2005 Feb; 65(1):152-4. PubMed ID: 15893133
    [Abstract] [Full Text] [Related]

  • 6. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA, Lewanczuk RZ.
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [Abstract] [Full Text] [Related]

  • 7. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM, Moran A.
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [Abstract] [Full Text] [Related]

  • 8. Insulin resistance: trigger or concomitant factor in the metabolic syndrome.
    Avogaro A.
    Panminerva Med; 2006 Mar; 48(1):3-12. PubMed ID: 16633326
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
    Pantaleo A, Zonszein J.
    Heart Dis; 2003 Mar; 5(5):323-33. PubMed ID: 14503930
    [Abstract] [Full Text] [Related]

  • 12. Challenges associated with metabolic syndrome.
    Spinler SA.
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J, Kelley RO.
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dyslipidemia in the metabolic syndrome: clinical implications and management.
    Hafidh SA, Lavie CJ, Burns BP, Khan SS, Alpert MA.
    Minerva Cardioangiol; 2006 Apr; 54(2):215-27. PubMed ID: 16778753
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.